| Financial Year |
March 31 2023 |
| Monetary Funds |
5,380,245,804.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
25,957,126.58 |
| Accounts Receivable |
1,378,835,606.39 |
| Advances to Suppliers |
55,860,357.26 |
| Other Receivables |
30,143,506.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,050,675,323.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,140,806.56 |
| Total Current Assets |
8,038,584,574.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,250,655,851.40 |
| Under-construction Projects |
396,630,668.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
207,250,415.24 |
| R&D expenses |
-- |
| Goodwill |
645,965,288.52 |
| Long-Term Deferred and Prepaid Expenses |
31,131,403.62 |
| Deferred Income Tax Assets |
118,748,015.74 |
| Other Non-Current Assets |
6,213,661.12 |
| Sub-Total of Non-Current Assets |
2,728,993,484.78 |
| Total Assets |
10,767,578,059.51 |
| Short-Term Loans |
2,530,311,527.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
384,018,000.00 |
| Accounts Payable |
1,058,340,558.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
130,338,263.28 |
| Taxes Payable |
46,485,899.77 |
| Interest Payable |
-- |
| Dividend Payable |
18,366,120.00 |
| Other payables |
332,153,215.16 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
518,951,890.45 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
5,294,724,517.08 |
| Long-term Loans |
-- |
| Bonds Payable |
1,109,270,331.37 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
277,218,334.22 |
| Deferred Income Tax Liabilities |
36,288,227.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,478,827,726.58 |
| Total Liabilities |
6,773,552,243.66 |
| Paid-In Capital(Or Share Stock) |
574,031,360.00 |
| Capital Surplus |
861,029,073.66 |
| Surplus Reserve |
287,015,680.00 |
| LESS:Treasury Stock |
51,431,112.86 |
| Undistributed Profits |
2,222,232,158.02 |
| Minority Stockholder's Interest |
2,882,049.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,991,143,766.06 |
| Owner's Equity（Stockholder's Equity） |
3,994,025,815.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,767,578,059.51 |
